Tag: presence

MONTVILLE, N.J., July 25, 2025 (GLOBE NEWSWIRE) -- Rate, a leading fintech company, proudly announces the addition of Brian Bloete, a decorated U.S. Marine Corps veteran and top-producing loan officer, to its team in Montville, NJ. Bloete joins Rate as part of the company’s continued commitment to attracting elite originators who prioritize service, integrity, and performance.

DUBLIN, July 25, 2025 (GLOBE NEWSWIRE) -- Fusion Fuel Green PLC (NASDAQ: HTOO) (“Fusion Fuel” or the “Company”), a provider of integrated energy solutions, today announced that, in July 2025, its majority-owned operating subsidiary, Al Shola Al Modea Gas Distribution LLC (“Al Shola Gas”), confirmed a number of new projects for the installation and maintenance of liquefied petroleum gas (“LPG”) systems and the supply of bulk LPG across multiple large-scale residential and commercial developments in Dubai, United Arab Emirates.

NEW YORK and MAINZ, GERMANY, July 25, 2025 — Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) announced today that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for the companies’ LP.8.1-adapted monovalent COVID-19 vaccine (COMIRNATY^® LP.8.1) for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older. The adaptation is based on the recommendation from the EMA’s Emergency Task Force (ETF) to update COVID-19 vaccines to target the LP.8.1 variant for the 2025-2026 season. The ETF stated that “targeting LP.8.1 will help maintain the effectiveness of the vaccines as SARS-CoV-2 continues to evolve.”²

Schlieren / Zurich, Switzerland, 25 July, 2025 – Memo Therapeutics AG ("MTx”), a late-stage biotech company translating unique immune responses into superior medicines to treat viral infections and cancer, today announced results from its Phase II clinical trial evaluating potravitug, a highly potent human BK polyomavirus (“BKPyV”)-neutralizing monoclonal antibody, for the treatment of BKPyV infection in kidney transplant recipients (“KTR”).

Vancouver, BC, July 24, 2025 (GLOBE NEWSWIRE) -- Pinnacle Food Group Limited (NASDAQ: PFAI) (“PFAI” or “the Company”), a leading innovator in the smart farming industry, is pleased to announce the appointment of Dunruo Andrew Zhu as President of Asia Pacific, effective immediately. With over 30 years of experience in commercial real estate and a proven track record of leadership, Mr. Zhu will spearhead the Company’s expansion strategy across the Asia Pacific region.